Cardiol Therapeutics Inc (CRDL) Stock Price, Quote, News & History

CRDLNASDAQ
$1.84
-0.01-0.54%
Last update: Sep 16, 9:30 AM

Cardiol Therapeutics (CRDL) Stock Price, Quote, News & History | Benzinga

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change

Cash Flows

Operating Cash Flow (TTM)
-24.05M
Investing Cash Flow (TTM)
-56.72K
Financing Cash Flow (TTM)
31.61M
Free Cash Flow (TTM)
-24.10M
Capital Expenditure (TTM)
-56.72K
Net Change in Cash (TTM)
7.51M

Analyst Trends and Forecast

1
Apr
1
Jul
1
Aug
Buy
Hold
Sell
Strong Sell

Analyst Rating and Forecast

12345
4.0
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Valuation Metrics

Enterprise Value
$198.14M
PE Ratio (TTM)
-
PE Ratio (FWD)
-
PEG Ratio (TTM)
-
PS Ratio (TTM)
-
PB Ratio (TTM)
12.47
Earnings Yield % (TTM)
-13.25%
Earnings Yield % (FWD)
-10.52%
EV / EBITDA (TTM)
-
Price / EBITDA (TTM)
-
Price / Free Cash Flow (TTM)
-
Book Value / Share
$0.15

Company Debt

Total Debt
-
LT Debt
-
LT Debt Issuance (TTM)
-
LT Debt Repayment (TTM)
-$55.38K
Total Cash
$26.08M
Debt to Equity
0.00
Issuance of Debt (TTM)
-$55.38K
Repayment of Debt (TTM)
-$55.38K

Key Statistics

Open
$1.87
Close
-
Volume / Avg.
706.36K / 1.10M
Day Range
$1.83 - $1.88
52 Wk Range
0.88 - 2.34
Market Cap
$214.95M
P/E Ratio
-
Dividend Yield
-
Exchange
NASDAQ
RSI
47
Short Interest
2.57%
Days to Cover
1.64

About

Sector
Health Care
Industry
Pharmaceuticals
Cardiol Therapeutics Inc is a late-stage life sciences company focused on advancing the development of anti-inflammatory and anti-fibrotic therapies for heart disease. Its primary small-molecule candidate, CardiolRx, targets inflammasome pathway acti...
Show More
Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

FAQ

Q

How do I buy Cardiol Therapeutics (CRDL) stock?

A

You can purchase shares of Cardiol Therapeutics (NASDAQ:CRDL) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Cardiol Therapeutics (CRDL) competitors?

Q

What is the forecast, or price target, for Cardiol Therapeutics (CRDL) stock?

A

Cardiol Therapeutics has a consensus price target of $9.50.

Q

What is the current price for Cardiol Therapeutics (CRDL)?

A

The stock price for Cardiol Therapeutics (NASDAQ: CRDL) is $1.84 last updated September 16, 2026 at 9:30 AM EDT.

Q

Does Cardiol Therapeutics (CRDL) pay a dividend?

A

There are no upcoming dividends for Cardiol Therapeutics.

Q

When is Cardiol Therapeutics (NASDAQ:CRDL) reporting earnings?

A

Cardiol Therapeutics does not have any upcoming earnings scheduled.

Q

Is Cardiol Therapeutics (CRDL) going to split?

A

There is no upcoming split for Cardiol Therapeutics.

Q

What sector and industry does Cardiol Therapeutics (CRDL) operate in?

A

Cardiol Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.